Product Information
LUIZZA 1.5 MG-30 MCG TABLET is a generic product labeled by Xiromed LLC, priced at $0.3556 per EA under NDC 70700031479. Its NADAC has been published 35 times since Oct 29, 2025.
Strength
30; 1.5 ug/1; mg/1
Manufacturer
Xiromed LLCNDC
70700031479
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA202770On Market Since
1/29/2025
Price Statistics
The NADAC for LUIZZA 1.5 MG-30 MCG TABLET has been published 35 times since Oct 29, 2025, and over the history we have for it it has declined 7.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3556 per EA |
|---|---|
| All-time high | $0.3923 (Dec 10, 2025) |
| All-time low | $0.3344 (Mar 18, 2026) |
| 52-week high | $0.3923 |
| 52-week low | $0.3344 |
| Median price | $0.3556 |
| Average price | $0.3638 |
| Largest weekly change | -7.8% (Feb 18, 2026) |
| Weeks tracked | 35 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the norethindrone acetate and ethinyl estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LUIZZA 1.5 MG-30 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LUIZZA 1.5 MG-30 MCG TABLET, manufactured by Xiromed LLC, is $0.3556 per EA (NDC 70700031479), effective Jun 24, 2026.
How has the price of LUIZZA 1.5 MG-30 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LUIZZA 1.5 MG-30 MCG TABLET has declined 7.3%. It has been tracked across 35 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for LUIZZA 1.5 MG-30 MCG TABLET?
Since Oct 29, 2025, the NADAC for LUIZZA 1.5 MG-30 MCG TABLET has ranged from a low of $0.3344 (Mar 18, 2026) to a high of $0.3923 (Dec 10, 2025), with a median of $0.3556 per EA.
Are there cheaper alternatives to LUIZZA 1.5 MG-30 MCG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LUIZZA 1.5 MG-30 MCG TABLET, so no direct lower-cost alternative is listed.
Who manufactures LUIZZA 1.5 MG-30 MCG TABLET?
LUIZZA 1.5 MG-30 MCG TABLET (NDC 70700031479) is labeled by Xiromed LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification